DUBLIN, Jan 20, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Europe Breast Cancer Epidemiology and Patient Flow Analysis - 2017" report to their offering.
The report provides insights into Breast Cancer epidemiology, Breast Cancer diagnosed patients, and Breast Cancer treatment rate for EU5 pharmaceutical markets.
The study measures key indicators such as prevalence of Breast Cancer derived from epidemiological analysis, percentage of patients diagnosed with Breast Cancer, and percentage of patients treated with a therapy.
The study helps executives estimate Breast Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Breast Cancer prevalence, Breast Cancer diagnosis rate, and Breast Cancer treatment rate for the period 2016 - 2025.
Key Features of the Report:
- Breast Cancer Patient Flow
- Breast Cancer Prevalence
- Breast Cancer Diagnosed Patients
- Breast Cancer Treated Patients
Key Topics Covered:
1. Breast Cancer: Disease Definition
2. Breast Cancer Patient Flow in Europe
3. Breast Cancer Patient Flow in Germany
4. Breast Cancer Patient Flow in France
5. Breast Cancer Patient Flow in Spain
6. Breast Cancer Patient Flow in Italy
7. Breast Cancer Patient Flow in UK
For more information about this report visit http://www.researchandmarkets.com/research/spnb7m/europe_breast
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets